Anna Christina Dragon

5PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2026
Inducible IL-12 or IL-18 secreting CAR T cells targeting the glyco-antigen CD176 exhibit potent activity against non-small cell lung cancer in preclinical models.

|Dec 19, 2025
Vitamin C Conditioning Generates Tumor-Targeting CAR T Cells with Superior Cytotoxicity and Fitness in a Posttransplant Lymphoproliferative Disorder Tumor Model.

Pegah Rahmati, Agnes Bonifacius, Anna Christina Dragon

|Oct 21, 2025
LMP2A-Targeting CAR-T Cells Equipped With Inducible IL-18 to Address EBV-Associated Malignancies.

Anna Christina Dragon, Stefanie Thoelke, Philip Mausberg

|Apr 23, 2022
Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy.

Miriam Laubert, Agnes Bonifacius, Anna Christina Dragon

|Oct 31, 2020
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation.

Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter

Pageof 1

Frequent Collaborators

3 joint publications

Agnes Bonifacius

3 joint publications

Rainer Blasczyk

3 joint publications

Britta Eiz-Vesper

2 joint publications

Jochen Huehn